C. Lisanti
Centro di Riferimento Oncologico(IT)Istituti di Ricovero e Cura a Carattere Scientifico(IT)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Inflammatory Biomarkers in Disease Prognosis, Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease(2015)465 cited
- → Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside(2019)128 cited
- → Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects(2022)120 cited
- → The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients(2019)79 cited
- → Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for a Cost-Effective and Dynamic Biomarker(2019)60 cited
- → Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study(2020)35 cited
- → Atezolizumab for the treatment of breast cancer(2018)29 cited
- → The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer(2020)28 cited
- → Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis(2020)27 cited
- → Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer(2021)15 cited